| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/27/2010 | US7763589 Administering a vector construct that expresses an immunogenic portion of an antigen derived from a pathogen, and administering an immunogenic protein of said antigen, to generate an immune response |
| 07/27/2010 | US7763466 Generating cells for cell replacement therapy |
| 07/27/2010 | US7763422 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 07/27/2010 | US7763249 Brain protein specific immunoglobulin for use in diagnosis, prevention and treatment of alzheimer's disease |
| 07/27/2010 | US7763243 Arming of activated T cells with BiAbs increases the effective precursor frequency of CTL in the cancer patient. |
| 07/27/2010 | CA2430112C Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 07/27/2010 | CA2404000C A functional assay of high-density lipoprotein |
| 07/27/2010 | CA2323091C Nephrin gene and protein |
| 07/27/2010 | CA2263152C Immunologically active proteins from borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines |
| 07/27/2010 | CA2237717C Screening assay for compounds stimulating somatostatin and insulin production |
| 07/27/2010 | CA2236982C The use of lecithin-cholesterol acyltransferase (lcat) in the treatment of atherosclerosis |
| 07/22/2010 | WO2010083338A2 Modulation of pre-mrna using splice modulating oligonucleotides as therapeutic agents in the treatment of disease |
| 07/22/2010 | WO2010083162A2 Unc-45a splice variants based cancer diagnostics and therapeutics |
| 07/22/2010 | WO2010082622A1 NOVEL HIGH-FUNCTION ENZYME OBTAINED BY ALTERING SUBSTRATE SPECIFICITY OF HUMAN β-HEXOSAMINIDASE Β |
| 07/22/2010 | WO2010081185A1 Compositions for the treatment of gluten intolerance and uses thereof |
| 07/22/2010 | WO2010062394A3 Implantable ocular drug delivery device and methods |
| 07/22/2010 | WO2010060430A3 Optimized influenza vaccines |
| 07/22/2010 | WO2010059004A9 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient |
| 07/22/2010 | WO2010038965A3 GCH1-TARGETED si RNA, RECOMBINANT VECTOR CONTAINING si RNA, AND PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT VECTOR FOR TREATING AND PREVENTING NEUROPATHIC PAIN |
| 07/22/2010 | US20100186097 Cell-based rna interference and related methods and compositions |
| 07/22/2010 | US20100184953 Stable lipid-comprising drug delivery complexes and methods for their production |
| 07/22/2010 | US20100184845 Myeloid Colony Stimulating Factor and Uses Thereof |
| 07/22/2010 | US20100184844 Inhibition of Bacterial Protein Production by Polyvalent Oligonucleotide Modified Nanoparticle Conjugates |
| 07/22/2010 | US20100184833 Methods and means for treating dna repeat instability associated genetic disorders |
| 07/22/2010 | US20100184828 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184827 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184826 Methods and compositions for enhancing the efficacy and specificity of rna silencing |
| 07/22/2010 | US20100184825 for treating, preventing, inhibiting, or reducing obesity, insulin resistance, diabetes and any other disease, trait, or condition that is related to or will respond to the levels of PTP-1B in a cell or tissue |
| 07/22/2010 | US20100184797 Treatment of dyskinesia |
| 07/22/2010 | US20100184672 Protein c for use in maintaining hemostasis |
| 07/22/2010 | US20100184211 Tumour-Associated Peptides that Bind to MHC Molecules |
| 07/22/2010 | US20100184207 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules |
| 07/22/2010 | US20100184206 Targeting pseudotyped retroviral vectors |
| 07/22/2010 | US20100184091 Method for determining MIF content |
| 07/22/2010 | US20100184023 Prostate Specific Gene, PCGEM1, and Methods of Using PCGEM1 to Detect, Treat, and Prevent Prostate Cancer |
| 07/22/2010 | US20100183705 Phospholipid-analogous compounds |
| 07/22/2010 | US20100183645 Active or passive immunization against proapoptotic neurotrophins for the treatment and/or prevention of neurodegenerative diseases |
| 07/22/2010 | US20100183644 Tumour-Associated Peptides that Bind to MHC Molecules |
| 07/22/2010 | US20100183639 Nucleic acid-lipophilic conjugates |
| 07/22/2010 | US20100183609 Taci-immunoglobulin fusion proteins |
| 07/22/2010 | US20100183560 Angiogenesis-modulating compositions and uses |
| 07/22/2010 | US20100183556 Recombinant expression vector system for variants of coagulation factor VIII and von Willebrand factor |
| 07/22/2010 | US20100183548 Tweak receptor |
| 07/22/2010 | CA2750379A1 Modulation of pre-mrna using splice modulating oligonucleotides as therapeutic agents in the treatment of disease |
| 07/21/2010 | EP2208736A2 Endogenous retrovirus up-regulated in prostate cancer |
| 07/21/2010 | EP2208499A1 Nucleic acid capable of regulating the proliferation of cell |
| 07/21/2010 | EP1581056B1 Therapeutic retroviral vectors for gene therapy |
| 07/21/2010 | EP1567197B1 Compositions for treating or preventing angiogenesis-dependent symptoms |
| 07/21/2010 | EP0724642B2 Nucleotide vector, composition containing such vector and vaccine for immunization against hepatitis |
| 07/21/2010 | EP0702566B1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 07/21/2010 | CN101781662A Human and mammal cell free expression vector |
| 07/21/2010 | CN101781636A Proliferous type recombination oncolytic adenovirus containing 11-type adenovirus cilia protein gene, construction method and application thereof |
| 07/21/2010 | CN101781373A Salbutamol modified guanidinated chitosan and preparation method and application thereof |
| 07/21/2010 | CN101781368A Anti-amyloid beta antibodies and their use |
| 07/21/2010 | CN101780283A Application of signal adjusting protein alpha in preparation of DC vaccine for preventing and treating tumors |
| 07/21/2010 | CN101780272A Application of autovaccine preparation containing TGF beta 1 |
| 07/21/2010 | CN101780269A Application of cell growth factor in treatment of ulcerative diseases and pulmonary fibrosis |
| 07/21/2010 | CN101380310B Composition of bFGF modified liposome and shRNA expression vector targeting human VEGF gene and preparation method thereof |
| 07/20/2010 | US7759479 modulating the expression of a Gemin Gene; used in manufacture of a medicament for treatment of diseases and disorders |
| 07/20/2010 | US7759477 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 07/20/2010 | US7759476 Double-stranded RNAS directed to IKK-2 |
| 07/20/2010 | US7759463 RNA interference pathway genes as tools for targeted genetic interference |
| 07/20/2010 | US7759319 Oligomeric compounds and compositions for use in modulation of pri-mirnas |
| 07/20/2010 | US7759318 Identification of novel pathways, genes and promoter motifs regulating adipogenesis |
| 07/20/2010 | US7759091 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor; apoptosis-inducing factor |
| 07/20/2010 | US7759078 Diagnosis and treatment of cancer |
| 07/20/2010 | US7758876 Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides |
| 07/20/2010 | US7758865 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs |
| 07/20/2010 | US7758858 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 07/20/2010 | US7758855 DNA promoters and anthrax vaccines |
| 07/20/2010 | US7758854 Anti-microbial agents |
| 07/20/2010 | CA2446942C Use of il-18 inhibitors for the treatment or prevention of sepsis |
| 07/20/2010 | CA2421339C Novel polypeptides and nucleic acids encoding the same |
| 07/20/2010 | CA2394648C Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another enteric pathogen |
| 07/20/2010 | CA2370519C Nucleic acids encoding a mutt domain-containing polypeptide |
| 07/20/2010 | CA2329659C Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 07/20/2010 | CA2197235C Adenovirus comprising a gene coding for glutathion peroxidase |
| 07/20/2010 | CA2191063C Dna encoding glutamate gated chloride channels |
| 07/15/2010 | WO2010080183A1 Potent non-urea inhibitors of soluble epoxide hydrolase |
| 07/15/2010 | WO2010079978A2 Composition for improving inflammatory disease using abh antigens |
| 07/15/2010 | WO2010079833A1 Novel cancer antigen eef2 |
| 07/15/2010 | WO2010079819A1 Pharmaceutical composition for treating obesity or diabetes |
| 07/15/2010 | WO2010079811A1 Gene sensitive to diseases associated with intervertebral disc degeneration, and use thereof |
| 07/15/2010 | WO2010078842A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
| 07/15/2010 | WO2010053561A3 Dendritic cell modulation in post-ischemic wounds |
| 07/15/2010 | WO2010040112A3 Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1 |
| 07/15/2010 | WO2010033871A3 Compositions and methods targeting glutaminase |
| 07/15/2010 | US20100179309 MODIFIED iRNA AGENTS |
| 07/15/2010 | US20100179212 Pharmaceutical composition which improves in vivo gene transfer |
| 07/15/2010 | US20100178302 Chronic pathogen-expressing cell lines |
| 07/15/2010 | DE102009004204A1 Verfahren zur verbesserten Bioaktivierung von Arzneistoffen The method for enhanced bioactivation of drugs |
| 07/15/2010 | CA2749180A1 Gene encoding human glucokinase mutant, enzyme encoded by the same, recombinant vectors and hosts, pharmaceutical compositions and uses thereof, methods for treating and preventing diseases |
| 07/14/2010 | EP2206787A2 Peptide-enhanced transfections |
| 07/14/2010 | EP2206785A1 Improved expression of HIV polypeptides and production of virus-like particles |
| 07/14/2010 | EP2206781A2 Antisense oligonucleotides for inducing exon skipping and methods of use thereof |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2205747A1 Attenuated invasive e. coli strains and applications thereof as intracellular vector for therapeutic molecule |
| 07/14/2010 | EP2205272A2 Molecular adjuvant |
| 07/14/2010 | EP1808488B1 DNA sequences having anti-repressor activity |